VRTX DMA



As of date:5/7/2026
VRTX stock price:425.00
VRTX 50 DMA:449.09
VRTX 200 DMA:435.48
VRTX MACD (200-50):-13.61

Also see:
VRTX Market Cap History
VRTX Shares Outstanding History
VRTX YTD Return
VRTX RSI
VRTX MACD
VRTX Technical Analysis

Artivion Stock Enters Oversold Territory as RSI Falls to 24.1
1 hour, 9 minutes ago


Element Fleet Management Stock Enters Oversold Territory as RSI Falls Below 30
1 hour, 10 minutes ago


Direxion Daily AAPL Bear 1X Shares Enters Oversold Territory as Apple Rally Pressures Inverse ETF
1 hour, 37 minutes ago


Phibro Animal Health Stock Enters Oversold Territory as Dividend Investors Review PAHC
1 hour, 49 minutes ago


Cheniere Energy Stock Enters Oversold Territory as RSI Falls Below 30
2 hours, 4 minutes ago


Compass Diversified Preferred Stock Yield Tops 9% as Series C Trades at a Double-Digit Discount
2 hours, 40 minutes ago


Zoetis Stock Enters Oversold Territory as Dividend Yield Rises
Thursday, May 7, 4:56 PM


UGI Stock Enters Oversold Territory as RSI Falls Below 30
Thursday, May 7, 4:51 PM


CNX Resources Stock Enters Oversold Territory as RSI Falls Below 30
Thursday, May 7, 4:46 PM


Unusual Options Volume Thursday: CODI, CLDT, and COST Stand Out
Thursday, May 7, 3:19 PM


Energy and Materials Lead Thursday Sector Declines as XLE and XLB Slide
Thursday, May 7, 3:09 PM


IBM Dividend Analysis: Why International Business Machines Remains a Top Dividend Giant
Thursday, May 7, 7:25 AM


Texas Instruments Risk Factors: What TXN's 10-K Really Means for Investors
Thursday, May 7, 7:10 AM


Oppenheimer Holdings Stock Falls Below Book Value as OPY Shares Retreat
Wednesday, May 6, 4:33 PM


Alcon Stock Enters Oversold Territory as RSI Falls Below 30
Wednesday, May 6, 4:32 PM


More Technical Analysis News

VRTX DMAVRTX MACD
Vertex Pharmaceuticals Incorporated is a global biotechnology company. Co. is focused on investing in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has four approved medicines that treat the underlying cause of cystic fibrosis (CF), and one approved therapy that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT). Its pipeline includes clinical-stage programs in CF, SCD, TDT, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.

When researching a stock like Vertex Pharmaceuticals, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from VRTX Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for VRTX stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the VRTX 200 day moving average ("VRTX 200 DMA"), while one of the most popular "shorter look-backs" is the VRTX 50 day moving average ("VRTX 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Vertex Pharmaceuticals.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree VRTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Video: Technical Analysis
Vertex Pharmaceuticals (VRTX) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

VTRS DMA
WAT DMA
WST DMA
ZBH DMA
ZTS DMA
A DMA
ABBV DMA
ABT DMA
ALGN DMA
AMGN DMA
More Healthcare companies »
 

VRTX DMA | www.StockDMA.com | Copyright © 2019 - 2026, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.